75% Objective Response Rate as 12 out of 16 advanced melanoma patients had objective clinical responses, with 11 of the 12 responders continuing to respond at 24 months follow-up Immune activation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback